PSMA PET/CT for the Targeting of Prostate Biopsies: Additional Value over MRI?

被引：0
|
作者：
Morre, C. J. W. M. [1 ]
Boer, J. J. [1 ]
Rynja, S. P. [1 ]
Hagens, M. J. [2 ]
Noordzij, M. A. [1 ]
机构：
[1] Spaarne Gasthuis, Hoofddorp, Netherlands
[2] Antoni Leeuwenhoek Canc Inst, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-042
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [21] The additional value of 18F-FDG PET/CT compared to 68Ga-PSMA-11 PET/CT in initial diagnosed prostate cancer patients
    Wang, Yining
    Liu, Jianjun
    Chen, Ruohua
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [22] Additional value of systematic biopsies for preoperative assessment in MRI-detected prostate cancer
    Axen, E. C.
    Arnsrud, Godtman R.
    Hugosson, J.
    Stranne, J.
    EUROPEAN UROLOGY, 2021, 79 : S1336 - S1336
  • [23] PSMA PET/CT and PET/MRI in primary staging of prostate cancer and its effect on patient management
    Pieter Claes
    Niloefar Ahmadi Bidakhvidi
    Alexander Giesen
    Steven Joniau
    Koen Van Laere
    Michel Koole
    Sander Jentjens
    Christophe M. Deroose
    Karolien Goffin
    Clinical and Translational Imaging, 2024, 12 : 31 - 54
  • [24] PSMA PET/CT and PET/MRI in primary staging of prostate cancer and its effect on patient management
    Claes, Pieter
    Bidakhvidi, Niloefar Ahmadi
    Giesen, Alexander
    Joniau, Steven
    Van Laere, Koen
    Koole, Michel
    Jentjens, Sander
    Deroose, Christophe M.
    Goffin, Karolien
    CLINICAL AND TRANSLATIONAL IMAGING, 2024, 12 (01) : 31 - 54
  • [25] Reply: "The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer"
    Hoffmann, Manuela A.
    Wieler, Helmut J.
    Baues, Christian
    Kuntz, Nicholas J.
    Richardsen, Ines
    Schreckenberger, Mathias
    UROLOGY, 2019, 131 : 262 - 263
  • [26] PSMA PET/CT vs MRI for GTV delineation in prostate cancer: a comparison with histology
    Zamboglou, C.
    Drendel, V.
    Jilg, C. A.
    Rischke, H. C.
    Teresa, B., I
    Krauss, T.
    Werner, M.
    Bock, M.
    Langer, M.
    Meyer, P. T.
    Grosu, A. L.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S294 - S294
  • [27] COMPARING PSMA PET/CT AND MRI WITH BIOPSY FINDINGS IN THE INITIAL DIAGNOSIS OF PROSTATE MALIGNANCY
    Paterson, F.
    Nottage, M.
    Kitchener, M.
    Oakden-Raynor, L.
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 7 - 7
  • [28] PSMA PET/CT vs. Pelvic MRI in Biochemically Recurrent Prostate Cancer
    Murthy, Vishnu
    Sonni, Ida
    Mehta, Raj
    Chung, Alex
    Unterrainer, Lena
    Hotta, Masatoshi
    Farolfi, Andrea
    Benitez, Cecil
    Armstrong, Wesley
    Doddipalli, Sahith
    Bandara, Anishka
    Valle, Luca
    Kishan, Amar
    Benz, Matthias
    Raman, Steven
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [29] MRI is more accurate than a PSMA PET/CT scan for prostate cancer diagnosis
    Nierengarten, Mary Beth
    CANCER, 2022, 128 (22) : 3906 - 3906
  • [30] Targeted biopsies are redundant in mp-MRI and PSMA- PET proven radiorecurrent prostate cancer
    Peters, M.
    van Son, M.
    Rasing, M.
    Lagendijk, J.
    Moerland, M.
    van de Pol, S.
    Eppinga, W.
    Jonges, T.
    Wessels, F.
    de Keizer, B.
    Noteboom, J.
    van Zyp, J. van der Voort
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1124 - S1125
12345